Steroid Biosynthesis in Gonadal Tissue from Patients with Testicular Feminization

1972 ◽  
Vol 50 (8) ◽  
pp. 849-855 ◽  
Author(s):  
C. Cardiff ◽  
V. Uden ◽  
D. W. Killinger

The biosynthesis of sulfate conjugates and unconjugated steroids has been compared in two siblings aged 19 and 21, and a 52-year-old patient with the complete form of testicular feminization. Incubation of homogenates of gonadal tissue with 14C-pregnenolone (P) and 3H-pregnenolone-sulfate (PS) revealed that the conversion of P to PS was 6.8% in the older subject, and less than 1% in the two younger subjects; and the conversion to dehydroepiandrosterone sulfate (DHAS) was 24.2% in the older subject, and 2.1 and 0.2% in the two younger subjects. The recovery of unmetabolized PS was 41.9% in the older subject, and 5.0 and 13.7% in the two younger subjects. The formation of testosterone from P was 4.2 and 2.2% in the two younger subjects, and 0.5% in the older subject, and the 3H/14C ratio indicated that the utilization of PS in testosterone biosynthesis was greater in the younger patients than in the older subject. Incubation of 14C-dehydroepiandro-sterone (D) and 3H-DHAS with testicular tissue from the 21-year-old subject confirmed the high testosterone production and steroid sulfate utilization in the younger subject.These findings raise the possibility that with age there may be a shift from the biosynthesis of biologically active unconjugated products to less biologically active sulfate conjugates in testicular tissue.

1968 ◽  
Vol 42 (3) ◽  
pp. 391-403 ◽  
Author(s):  
A. P. WADE ◽  
G. S. WILKINSON ◽  
J. C. DAVIS ◽  
T. N. A. JEFFCOATE

SUMMARY [4-14C]Testosterone, [4-14C]androstenedione and [4-14C]oestrone were incubated with testicular tissue obtained from an 18-yr.-old patient with the complete form of the testicular feminization syndrome. Considerable biosynthesis of testosterone from androstenedione occurred, but metabolism of testosterone by the tissue was minimal. The small phenolic fraction from these incubations did not contain any recognizable oestrogens. Metabolism of oestrone was almost complete, less than 4% being recovered as unchanged oestrone. Of eight areas of radioactivity found during chromatography, five were shown to be associated with oestrone, 2-methoxyoestrone, oestradiol-17β, 2-hydroxyoestradiol-17β, and 2-methoxy-oestradiol-17β. Chromatographic evidence suggested that an oxo-oestrone and a compound more polar than oestriol were present. No oestriol was found. The results confirm those of other workers to the effect that testosterone is the major metabolite of androstenedione in feminizing testes. Incubation of the testes with oestrone showed them also to possess the enzyme systems necessary for hydroxylation at position 2 and the subsequent methylation of this group. Urinary steroid measurements before and after removal of the testes showed these organs to be actively secreting. Attempts to demonstrate oestrogenic activity in the urine additional to that accounted for by chemical estimation were unsuccessful.


1980 ◽  
Vol 95 (3) ◽  
pp. 314-318 ◽  
Author(s):  
Martha Medina ◽  
Alfredo Ulloa-Aguirre ◽  
Maria A. Fernández ◽  
Gregorio Pérez-palacios

Abstract. The role of oestrogens on gonadotrophin secretion was assessed in three related patients with the complete form of testicular feminization syndrome. Serum LH and FSH levels were measured before and after I.RH stimulation as well as before, during and after chronic clomiphene citrate administration. Moderately elevated LH basal levels with a significant LH rise following I.RH were observed. Normal or even low FSH level with poor response to LRH were found in all subjects. Administration of clomiphene citrate resulted in a significant serum LH increase without any change of FSH. Following castration both LH and FSH rose and a normal response to LRH was observed. These results were interpreted as demonstrating that, while endogenous oestrogens modulate LH secretion in patients with androgen unresponsiveness, it plays no role in regulating FSH secretion and suggested that a factor of testicular origin without androgenic or oestrogenic activity is responsible for FSH regulation.


2019 ◽  
Vol 31 (1) ◽  
pp. 145 ◽  
Author(s):  
S. Ledda ◽  
S. Pinna ◽  
S. Nieddu ◽  
D. Natan ◽  
A. Arav ◽  
...  

Vitrification is a method extensively used for preserving oocytes and embryos and is also gaining acceptance for preserving gonadal tissue. Cryopreservation of spermatogonial stem cells is an applicable method for young males seeking fertility preservation before starting a treatment or can be a tool for genetic preservation of rare or high-value animals. The aim of this work was to evaluate the cryopreservation of testicular tissue from young lambs by vitrification using a new device named E.Vit (FertileSafe, Ness Ziona, Israel) that permits all cryopreservation procedures to be performed in straw. The new device consists of a 0.3-mL straw (Cryo Bio System, IMV, L’Aigle, France) with a capsule containing 50-µm pores inserted at one end. Testicular tissue extracts were prepared from testes of slaughtered lambs (n=10, 40 days old), opened by sagittal sectioning with a microblade and collecting small pieces of testicular tissue (1mm3) from the middle part of the rete testis. Three pieces of gonadal tissue were inserted into each E.Vit device. Each straw was sequentially loaded vertically in two 1.5-mL microtubes, which contained the following solutions: first, the equilibrating solution (7.5% dimethyl sulfoxide+7.5% ethylene glycol+20% FCS in TCM-199) for 6min, followed by 90min in the vitrification solution (18% dimethyl sulfoxide+18% ethylene glycol+0.5M Trehalose+BSA in TCM-199). After exposure to the equilibrating solution and vitrification solution, the solutions were removed and the straws were directly loaded into LN2. The warming procedure consisted of placing the straws directly into 5-mL tubes containing 100, 50, and 25% warming solution (1M sucrose in TCM-199+20% FCS) at 38.6°C for 5min each before arrival into the holding medium. Samples were recovered from the straws incubated at 38.6°C in 5% CO2 in air in TCM 199+5% FCS and evaluated at 0 and 2h post-warming for viability using trypan blue staining. Expression of a panel of specific genes (SOD2, HSP90b, BAX, POUF5/OCT4, TERT, CIRBP, KIF11, AR, FSHR) was analysed by real-time PCR in cryopreserved tissue in vitro cultured for 2h post-warming (2hV), in fresh controls immediately after tissue dissection (0hF), and after 2h of in vitro culture (2hF). The majority of cells survived after vitrification, although viability immediately after warming (0hV: 56%±1.45) or after 2h of in vitro culture (IVC) (2hV: 54±7%) was significantly lower compared with non-cryopreserved fresh controls (0hF: 89%±1.45; ANOVA P<0.05). Expression analysis showed specific patterns for the different genes. Notably, BAX transcript abundance was not affected by vitrification or IVC, indicating an acceptable level of stress for the cells. The genes HSP90b and CIRBP were down-regulated in 2hF but increased in 2hV, as expected. Expression of SOD1 and OCT4 was altered by vitrification but not by IVC. Conversely, expression of TERT, KIF11, and AR was affected by both IVC and cryopreservation (ANOVA P<0.05). This novel protocol for testicular tissue cryopreservation of prepubertal animals may be a promising strategy for fertility preservation and can contribute as a new approach in the development of large-scale biodiversity programs.


Reproduction ◽  
2017 ◽  
Vol 153 (5) ◽  
pp. 555-563 ◽  
Author(s):  
Patricia G Oppelt ◽  
Andreas Müller ◽  
Liana Stephan ◽  
Ralf Dittrich ◽  
Johannes Lermann ◽  
...  

Patients with the Mayer–Rokitansky–Küster–Hauser syndrome (MRKH) have a congenital utero–vaginal cervical aplasia, but normal or hypoplastic adnexa and develop with normal female phenotype. Some reports mostly demonstrated regular steroid hormone levels in small MRKH cohorts including single MRKH patients with hyperandrogenemia and a clinical presentationof hirsutism and acne has also been shown. Genetically a correlation of WNT4 mutations with singular MRKH patients and hyperandrogenemia was noted. This study analyzed the hormone status of 215 MRKH patients by determining the levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, 17-OH progesterone, testosterone, dehydroepiandrosterone sulfate (DHEAS), sex hormone–binding globulin (SHBG) and prolactin to determine the incidence of hyperandrogenemia and hyperprolactinemia in MRKH patients. Additional calculations and a ratio of free androgen index and biologically active testosterone revealed a hyperandrogenemia rate of 48.3%, hyperprolactinemia of 9.8% and combined hyperandrogenemia and hyperprolactinemia of 4.2% in MRKH patients. The rates of hirsutism, acne and especially polycystic ovary syndrome (PCOS) were in the normal range of the population and showed no correlation with hyperandrogenemia. A weekly hormone assessment over 30 days comparing 5 controls and 7 MRKH patients revealed high androgen and prolactin, but lower LH/FSH and SHBG levels with MRKH patients. The sequencing of WNT4, WNT5A, WNT7A and WNT9B demonstrated no significant mutations correlating with hyperandrogenemia. Taken together, this study shows that over 52% of MRKH patients have hyperandrogenemia without clinical presentation and 14% hyperprolactinemia, which appeals for general hormone assessment and adjustments of MRKH patients.


1972 ◽  
Vol 69 (1) ◽  
pp. 119-126 ◽  
Author(s):  
Shutaro Mizutani ◽  
Takao Sonoda ◽  
Jun-ichi Furuyama ◽  
Michio Takemura ◽  
Keishi Matsumoto

ABSTRACT Gonadal tissues from a patient with true hermaphroditism were homogenized and incubated both separately and in combination with [4-14C] progesterone and [7α-3H] pregnenolone as substrates. The following metabolites were isolated and identified in the testicular portion from progesterone: 17-hydroxyprogesterone, 16α-hydroxyprogesterone, 20α-hydroxy-pregn-4-en-3-one, androst-4-ene-3,17-dione and testosterone. In addition, 17-hydroxypregnenolone, dehydroepiandrosterone and androst-5-ene-3β,17β-diol were isolated from pregnenolone as substrate. Incubation of the ovarian portion with progesterone gave 17-hydroxyprogesterone and 16α-hydroxyprogesterone. In addition, 17-hydroxypregnenolone and small amounts of dehydroepiandrosterone were isolated from pregnenolone. In these respects, the testicular portion resembled testicular tissue and the ovarian portion resembled the ovarian tissue of normal adults. Analysis of the products obtained suggest that this testicular tissue preferentially uses the Δ5-pregnenolone pathway rather than the Δ4-pro-gesterone pathway in its metabolic conversion to testosterone.


1974 ◽  
Vol 27 (2) ◽  
pp. 135-139
Author(s):  
E. Lockwood ◽  
P. C. Ghosh ◽  
G. W. Pennington ◽  
R. Tipton

2001 ◽  
Vol 47 (1) ◽  
pp. 30-34
Author(s):  
L. K. Dzeranova ◽  
M. E. Bronstein ◽  
E. I. Marova ◽  
A. V. Vorontsov ◽  
A. A. Pishchulin ◽  
...  

The article is devoted to the study of the complete form of the testicular feminization syndrome with dysherminoma in one testicle combiner with prolactinoma.


2018 ◽  
Vol 19 (12) ◽  
pp. 3804 ◽  
Author(s):  
Ali AbuMadighem ◽  
Ronnie Solomon ◽  
Alina Stepanovsky ◽  
Joseph Kapelushnik ◽  
QingHua Shi ◽  
...  

Aggressive chemotherapy may lead to permanent male infertility. Prepubertal males do not generate sperm, but their testes do contain spermatogonial cells (SPGCs) that could be used for fertility preservation. In the present study, we examined the effect of busulfan (BU) on the SPGCs of immature mice, and the possible induction of the survivor SPGCs to develop spermatogenesis in 3D in-vitro culture. Immature mice were injected with BU, and after 0.5–12 weeks, their testes were weighed and evaluated histologically compared to the control mice. The spermatogonial cells [Sal-like protein 4 (SALL4) and VASA (a member of the DEAD box protein family) in the testicular tissue were counted/seminiferous tubule (ST). The cells from the STs were enzymatically isolated and cultured in vitro. Our results showed a significant decrease in the testicular weight of the BU-treated mice compared to the control. This was in parallel to a significant increase in the number of severely damaged STs, and a decrease in the number of SALL4 and VASA/STs compared to the control. The cultures of the isolated cells from the STs of the BU-treated mice showed a development of colonies and meiotic and post-meiotic cells after four weeks of culture. The addition of homogenates from adult GFP mice to those cultures induced the development of sperm-like cells after four weeks of culture. This is the first study demonstrating the presence of biologically active spermatogonial cells in the testicular tissue of BU-treated immature mice, and their capacity to develop sperm-like cells in vitro.


Sign in / Sign up

Export Citation Format

Share Document